Drugs: the complete collection
 Drugs: the complete collection

SnortingEffectiveness bank home page. Opens new window Collection
Drugs: the complete collection

All Effectiveness Bank analyses to date of documents related to use and problem use of illegal drugs starting with the analyses most recently added or updated, totalling today 815 documents.

Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents



MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell E2: Treatment systems; Generic and cross-cutting issues

Ashton M.
Seminal and key studies on local, regional and national systems for effectively and cost-effectively providing drug addiction treatment. Commentary focuses on payment-by-results funding mechanisms, crime-reduction as a justification for treatment, and ways to improve treatment systems, especially the core care planning process.

STUDY 2017 HTM file
Does paying service providers by results improve recovery outcomes for drug misusers in treatment in England?

Jones A., Pierce M., Sutton M. et al.
Addiction: 2017, 113(2), p. 279–286.
Substance use treatment commissioned on a payment-by-results basis in England has been linked to higher rates of in-treatment abstinence and non-injecting than other commissioning models, but lower rates of treatment initiation and completion. Is this enough to support the policy?

STUDY 2013 HTM file
PROSPER community-university partnership delivery system effects on substance misuse through 6½ years past baseline from a cluster randomized controlled intervention trial

Spoth R., Redmond C., Shin C. et al.
Preventive Medicine: 2013, 56, p. 190–196.
Evaluated drug prevention programmes for adolescents are typically implemented by research teams, raising questions over real-world applicability and sustainability, but an important US trial is said to have robustly demonstrated the public health potential of a system in which the communities themselves take primary responsibility.

MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell C2: Management/supervision; Generic and cross-cutting issues

Ashton M.
Key studies on the role of management and supervision across psychosocial and medical treatments of problem drug use. Highlights that “Manners Matter”, asks, “Is there anything more instructive than being the patient?”, explores the role of patient choice and preferences in treatment planning, and queries the ubiquitous stages of change model. See the rest of row 2 of the matrix for more on features common to psychosocial and medical treatments.

HOT TOPIC 2017 HTM file
Focus on the families

Ashton M., Davies N.
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Both as a treatment resource for the patient and a group needing support in their own right, a UK report described families affected by substance use as the “forgotten” carers. Here we turn the focus on the “unheard and unseen victims when a loved one uses drugs or alcohol”.

HOT TOPIC 2017 HTM file
Does it matter if ‘addiction is a brain disease’

Ashton M.
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Dismissed as a chimera leading down expensive blind alleys or hailed as a scientific breakthrough and vindication for ‘sufferers’, the brain-disease model of addiction has been attracting research dollars and high-level support. True or false or somewhere in between, it has important implications for treatment.

MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell B2: Practitioners; Generic and cross-cutting issues

Ashton M.
At the front line the practitioner is to the patient the face of addiction treatment. Key research shows they can matter enormously – not so much in their formal qualifications, but in their manner with the patients. Probe with us the heart of addiction treatment: relationships.

MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell A2: Interventions; Generic and cross-cutting issues

Ashton M.
Seminal and key studies on features common to psychosocial therapy/support and medical treatment. Investigates where treatment is aiming to get to in the form of ‘recovery’, where it starts from as depicted in the brain-disease model of addiction, and the politics of the two most important British drug treatment studies.

STUDY 2017 HTM file
Recovery of infectious hepatitis C virus from injection paraphernalia: implications for prevention programs serving people who inject drugs

Heimer R., Binka M., Koester S. et al.
The Journal of Infectious Diseases: 2017, in press.
Resources spent on supplying ‘cookers’ and filters at needle exchanges may not help curb the spread of hepatitis C. Laboratory simulation suggests infections thought to be have been spread by sharing this equipment may be a proxy for transmission that occurs due to sharing blood-contaminated equipment for dividing drugs.

MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell E1: Local and national systems; Reducing harm

Ashton M.
Seminal and key studies relating to local, regional and national systems for effectively and cost-effectively reducing harm.


Select search results page

PREVIOUS | NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82